Uji klinis Migrain di Maryland
7 studi untuk Migrain mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 8 hingga 70 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05669703Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pharmasite Research, Inc. /ID# 227908, Baltimore
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05125302Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine
- Johns Hopkins Medicine, Baltimore
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07223008A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
- MedStar Health Research Institute, Olney
Menerima peserta
Usia 22 hingga 84 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07719608A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Headlands Research - PharmaSite, Pikesville
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- University of Maryland School of Medicine, Baltimore
Menerima pesertaFase 3
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT05164172Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
- National Intrepid Center of Excellence (NICOE), Bethesda
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Des 2025 · NCT07267819Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.